thiazoles has been researched along with Peripheral Vascular Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, JR; Biddlecome, G; Biswas, K; Bürli, RW; Chang, C; Dao, JH; Frohn, MJ; Hungate, RW; Peterkin, TA; Rogers, N; Tagari, P; Tegley, CM; Veith, H; Viswanadhan, VN; Yoder, SC | 1 |
| Nelissen, N; Thijs, VN; Van Laere, K; Vanacker, P | 1 |
| Harris, S; Hughes, K; Layton, D; Shakir, SA | 1 |
| Scuteri, A | 1 |
| Capriotti, A; Clattenburg, L; Corretti, MC; Gerstenblith, G; Kass, DA; Melenovsky, V; Zieman, SJ | 1 |
| Avena, R; Curry, KM; Mitchell, ME; Nylen, ES; Sidawy, AN | 1 |
1 trial(s) available for thiazoles and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension.
Topics: Aged; Aging; Blood Pressure; Carotid Arteries; Collagen; Elasticity; Endothelium, Vascular; Female; Glycation End Products, Advanced; Humans; Hypertension; Intercellular Adhesion Molecule-1; Male; Manometry; Matrix Metalloproteinase 9; Middle Aged; Peripheral Vascular Diseases; Single-Blind Method; Thiazoles; Transforming Growth Factor beta1; Vascular Cell Adhesion Molecule-1; Vasodilation | 2007 |
5 other study(ies) available for thiazoles and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation.
Topics: Chemistry, Pharmaceutical; Diabetes Mellitus; Drug Design; Drug Evaluation, Preclinical; Erythrocytes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inhibitory Concentration 50; Models, Chemical; Models, Molecular; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Structure-Activity Relationship; Thiazoles | 2008 |
Images in neurology. Scattered cerebral microbleeds due to cardiac myxoma.
Topics: Aniline Compounds; Carbon Radioisotopes; Cerebral Arteries; Cerebral Cortex; Cerebral Hemorrhage; Cerebrovascular Disorders; Echocardiography, Three-Dimensional; Female; Fibrinolytic Agents; Heart Atria; Heart Neoplasms; Humans; Intracranial Embolism; Magnetic Resonance Imaging; Middle Aged; Myxoma; Peripheral Vascular Diseases; Positron-Emission Tomography; Predictive Value of Tests; Thiazoles; Tissue Plasminogen Activator; Treatment Outcome | 2009 |
Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Celecoxib; Cerebrovascular Disorders; Chi-Square Distribution; Cohort Studies; Cyclooxygenase Inhibitors; England; Family Practice; Female; Humans; Incidence; Male; Meloxicam; Middle Aged; Osteoarthritis; Peripheral Vascular Diseases; Pyrazoles; Risk Factors; Sulfonamides; Survival Analysis; Thiazines; Thiazoles; Thromboembolism | 2003 |
Slowing arterial aging: how far have we progressed?
Topics: Aging; Blood Pressure; Glycation End Products, Advanced; Humans; Hypertension; Peripheral Vascular Diseases; Thiazoles | 2007 |
Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes.
Topics: Aged; Blood Flow Velocity; Brachial Artery; Chromans; Fasting; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peripheral Vascular Diseases; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |